Healthcare provider profile · identity verified

Peter J Franta, MD

Family Practice · LA CROSSE, WI · NPI 1619967155

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	926	253
Amlodipine Besylate	Amlodipine Besylate	559	143
Lisinopril	Lisinopril	439	117
Metoprolol Succinate	Metoprolol Succinate	409	99
Omeprazole	Omeprazole	357	86
Levothyroxine Sodium	Levothyroxine Sodium	301	73
Losartan Potassium	Losartan Potassium	271	73
Eliquis	Apixaban	256	43
Pantoprazole Sodium	Pantoprazole Sodium	239	60
Furosemide	Furosemide	229	45
Hydrochlorothiazide	Hydrochlorothiazide	217	57
Metformin Hcl Er	Metformin Hcl	217	55
Gabapentin	Gabapentin	208	60
Rosuvastatin Calcium	Rosuvastatin Calcium	207	50
Tamsulosin Hcl	Tamsulosin Hcl	204	51
Alendronate Sodium	Alendronate Sodium	168	46
Metoprolol Tartrate	Metoprolol Tartrate	150	39
Venlafaxine Hcl Er	Venlafaxine Hcl	146	22
Potassium Chloride	Potassium Chloride	131	31
Jardiance	Empagliflozin	128	23
Simvastatin	Simvastatin	128	41
Fluoxetine Hcl	Fluoxetine Hcl	124	21
Sertraline Hcl	Sertraline Hcl	122	25
Warfarin Sodium	Warfarin Sodium	115	31
Albuterol Sulfate Hfa	Albuterol Sulfate	106	37
Donepezil Hcl	Donepezil Hcl	102	14
Pravastatin Sodium	Pravastatin Sodium	98	22
Finasteride	Finasteride	97	23
Glipizide Er	Glipizide	89	21
Metformin Hcl	Metformin Hcl	88	22
Prednisone	Prednisone	88	34
Chlorthalidone	Chlorthalidone	84	22
Spironolactone	Spironolactone	84	24
Montelukast Sodium	Montelukast Sodium	80	12
Torsemide	Torsemide	80	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	79	24
Tramadol Hcl	Tramadol Hcl	76	14
Allopurinol	Allopurinol	75	18
Trazodone Hcl	Trazodone Hcl	74	19
Escitalopram Oxalate	Escitalopram Oxalate	73	18
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	68	20
Xarelto	Rivaroxaban	67	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	65	15
Ezetimibe	Ezetimibe	61	17
Bupropion Xl	Bupropion Hcl	60	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	59	11
Carbidopa-Levodopa	Carbidopa/Levodopa	57	suppressed
Duloxetine Hcl	Duloxetine Hcl	57	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	56	13
Pioglitazone Hcl	Pioglitazone Hcl	56	14
Buspirone Hcl	Buspirone Hcl	52	suppressed
Fluticasone Propionate	Fluticasone Propionate	50	17
Oxycodone Hcl	Oxycodone Hcl	50	15
Clopidogrel	Clopidogrel Bisulfate	49	16
Bisoprolol Fumarate	Bisoprolol Fumarate	48	14
Diclofenac Sodium	Diclofenac Sodium	48	suppressed
Lorazepam	Lorazepam	43	17
Ramipril	Ramipril	43	suppressed
Carvedilol	Carvedilol	38	14
Ozempic	Semaglutide	38	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	38	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	37	20
Mirtazapine	Mirtazapine	34	suppressed
Mounjaro	Tirzepatide	34	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	33	suppressed
Levetiracetam	Levetiracetam	33	suppressed
Clonazepam	Clonazepam	32	suppressed
Oxycontin	Oxycodone Hcl	32	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	32	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	31	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	30	suppressed
Baclofen	Baclofen	28	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	28	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	26	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	26	21
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	26	suppressed
Glimepiride	Glimepiride	26	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	26	suppressed
Paroxetine Hcl	Paroxetine Hcl	25	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	25	suppressed
Ventolin Hfa	Albuterol Sulfate	25	12
Chlorhexidine Gluconate	Chlorhexidine Gluconate	24	suppressed
Famotidine	Famotidine	24	suppressed
Nitroglycerin	Nitroglycerin	24	18
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	23	suppressed
Celecoxib	Celecoxib	23	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	23	suppressed
Alprazolam	Alprazolam	22	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	22	suppressed
Breo Ellipta	Fluticasone/Vilanterol	22	suppressed
Fenofibrate	Fenofibrate	22	suppressed
Ketoconazole	Ketoconazole	21	suppressed
Lovastatin	Lovastatin	21	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	21	suppressed
Pregabalin	Pregabalin	21	suppressed
Humalog Kwikpen U-100	Insulin Lispro	20	suppressed
Latanoprost	Latanoprost	20	suppressed
Naproxen	Naproxen	20	suppressed
Novolog Flexpen	Insulin Aspart	20	suppressed
Breyna	Budesonide/Formoterol Fumarate	19	suppressed
Caplyta	Lumateperone Tosylate	19	suppressed
Citalopram Hbr	Citalopram Hydrobromide	19	suppressed
Divalproex Sodium	Divalproex Sodium	19	suppressed
Insulin Aspart Flexpen	Insulin Aspart	19	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	19	suppressed
Penicillin V Potassium	Penicillin V Potassium	19	suppressed
Propranolol Hcl Er	Propranolol Hcl	19	suppressed
Benazepril Hcl	Benazepril Hcl	18	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	18	suppressed
Galantamine Er	Galantamine Hbr	18	suppressed
Meloxicam	Meloxicam	18	suppressed
Memantine Hcl	Memantine Hcl	18	suppressed
Trulicity	Dulaglutide	18	suppressed
Azithromycin	Azithromycin	17	suppressed
Cephalexin	Cephalexin	17	suppressed
Divalproex Sodium Er	Divalproex Sodium	17	suppressed
Cefadroxil	Cefadroxil	16	suppressed
Estradiol	Estradiol	16	suppressed
Primidone	Primidone	16	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	16	suppressed
Butalb-Acetaminoph-Caff-Codein	Butalbit/Acetamin/Caff/Codeine	15	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	15	13
Nystatin	Nystatin	15	suppressed
Olanzapine	Olanzapine	15	suppressed
Oxcarbazepine	Oxcarbazepine	15	suppressed
Ropinirole Hcl	Ropinirole Hcl	15	suppressed
Solifenacin Succinate	Solifenacin Succinate	15	suppressed
Spiriva Respimat	Tiotropium Bromide	15	suppressed
Synthroid	Levothyroxine Sodium	15	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	14	suppressed
Myrbetriq	Mirabegron	14	suppressed
Ranolazine Er	Ranolazine	14	suppressed
Carbamazepine	Carbamazepine	13	suppressed
Cefdinir	Cefdinir	13	12
Fluconazole	Fluconazole	13	suppressed
Glipizide	Glipizide	13	suppressed
Ibandronate Sodium	Ibandronate Sodium	13	suppressed
Leucovorin Calcium	Leucovorin Calcium	13	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	13	suppressed
Sotalol	Sotalol Hcl	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	suppressed
Xifaxan	Rifaximin	13	suppressed
Clobetasol Propionate	Clobetasol Propionate	12	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	12	suppressed
Levalbuterol Tartrate Hfa	Levalbuterol Tartrate	12	suppressed
Lithium Carbonate Er	Lithium Carbonate	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Restasis	Cyclosporine	12	suppressed
Asmanex Hfa	Mometasone Furoate	11	suppressed
Cimetidine	Cimetidine	11	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	11	suppressed
Entresto	Sacubitril/Valsartan	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error